2021 ICD-10-CM Code C79.11

Secondary malignant neoplasm of bladder

Version 2021
Billable Code
MS-DRG Mapping
Neoplasm Malignant Secondary

Valid for Submission

C79.11 is a billable diagnosis code used to specify a medical diagnosis of secondary malignant neoplasm of bladder. The code C79.11 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.

The ICD-10-CM code C79.11 might also be used to specify conditions or terms like malignant neoplasm of anterior wall of urinary bladder, malignant neoplasm of connective and soft tissue of abdominal wall, malignant neoplasm of lateral wall of urinary bladder, malignant neoplasm of posterior wall of urinary bladder, malignant tumor involving bladder by direct extension from endometrium , malignant tumor involving bladder by direct extension from fallopian tube, etc.

The following anatomical sites found in the Table of Neoplasms apply to this code given the correct histological behavior: Neoplasm, neoplastic bladder (urinary) ; Neoplasm, neoplastic bladder (urinary) dome ; Neoplasm, neoplastic bladder (urinary) neck ; Neoplasm, neoplastic bladder (urinary) orifice ; Neoplasm, neoplastic bladder (urinary) orifice ureteric ; Neoplasm, neoplastic bladder (urinary) orifice urethral ; Neoplasm, neoplastic bladder (urinary) sphincter ; etc

ICD-10:C79.11
Short Description:Secondary malignant neoplasm of bladder
Long Description:Secondary malignant neoplasm of bladder

Code Classification

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C79.11:


Type 2 Excludes

Type 2 Excludes
A type 2 excludes note represents "Not included here". An excludes2 note indicates that the condition excluded is not part of the condition represented by the code, but a patient may have both conditions at the same time. When an Excludes2 note appears under a code, it is acceptable to use both the code and the excluded code together, when appropriate.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

Convert C79.11 to ICD-9 Code

The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code C79.11 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.

Table of Neoplasms

The code C79.11 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »bladder (urinary)
C67.9C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »dome
C67.1C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »neck
C67.5C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »orifice
C67.9C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »orifice
      »ureteric
C67.6C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »orifice
      »urethral
C67.5C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »sphincter
C67.8C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »trigone
C67.0C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »urachus
C67.7C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
C67.9C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
      »anterior
C67.3C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
      »lateral
C67.2C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »bladder (urinary)
    »wall
      »posterior
C67.4C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »urachus
C67.7C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »ureter, ureteral
    »orifice (bladder)
C67.6C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »ureter-bladder (junction)
C67.6C79.11D09.0D30.3D41.4D49.4
»Neoplasm, neoplastic
  »urethra, urethral (gland)
    »orifice, internal
C67.5C79.11D09.0D30.3D41.4D49.4

Information for Patients


Bladder Cancer

The bladder is a hollow organ in your lower abdomen that stores urine. Bladder cancer occurs in the lining of the bladder. It is the sixth most common type of cancer in the United States.

Symptoms include

Risk factors for developing bladder cancer include smoking and exposure to certain chemicals in the workplace. People with a family history of bladder cancer or who are older, white, or male have a higher risk.

Treatments for bladder cancer include surgery, radiation therapy, chemotherapy, and biologic therapy. Biologic therapy boosts your body's own ability to fight cancer.

NIH: National Cancer Institute


[Learn More]

Code History

  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)